Target intelligence / Profile preview

Succinate–CoA ligase [GDP-forming] subunit beta, mitochondrial (SUCLG2)

Target
SUCLG2
Molecular classification
Enzyme
01

Overview

SUCLG2 is the gene encoding the mitochondrial GTP-specific succinyl-CoA synthetase beta subunit, a key enzyme in the citric acid (TCA) cycle that catalyzes the conversion of succinyl-CoA and GDP (plus inorganic phosphate) to succinate, CoA, and GTP. This enzyme complex is essential for mediating substrate-level phosphorylation in mitochondria and for maintaining mitochondrial energy metabolism. Mutations in the gene are associated with rare mitochondrial depletion syndromes and related metabolic diseases, indicating its critical physiological role in cellular energy homeostasis.

Other names
GTP-specific succinyl-CoA synthetase beta subunitSuccinyl-CoA synthetase beta-G chainSuccinyl-CoA ligase GDP-forming beta subunitGTP-specific succinyl-CoA synthetase subunit betaSuccinyl-CoA ligase, GDP-forming, beta chain, mitochondrialSCS-betaGGBETA
02

Biological functions

Citric acid cycle (tricarboxylic acid or TCA cycle)Substrate-level phosphorylation (GTP synthesis)Succinyl-CoA metabolic process
03

Disease associations

Mitochondrial DNA depletion syndrome 9Pyruvate dehydrogenase E1-alpha deficiencyOther mitochondrial metabolism disorders
04

Safety considerations

Mutations can cause mitochondrial disorders affecting energy metabolism, especially in tissues with high energy demand (e.g., brain, muscle)

Beyond the preview

Go deeper on Succinate–CoA ligase [GDP-forming] subunit beta, mitochondrial (SUCLG2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Succinate–CoA ligase [GDP-forming] subunit beta, mitochondrial (SUCLG2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call